Pharmacy in Czechia and Slovakia: €400 Apart

Czechia teaches pharmacy in English at two universities and Slovakia at one. All three are five-year Master of Pharmacy degrees inside the European Union.

The entire spread is EUR 400 a year. Set that against the European range for English-taught pharmacy, which runs from EUR 3,000 to EUR 44,286, and it is effectively a single price. Two of the three are identical to the euro, in different countries.

That is unusual and it is useful, because it means you can stop optimizing on cost. Across five years the gap between the cheapest and the most expensive of the three is EUR 2,000 — less than the difference one year of living costs makes between two cities. Choose on deadline, on selection method, and on whether you want to be in Brno, Bratislava or Hradec Kralove.

For scale: the median English-taught pharmacy fee outside the UK is EUR 8,000, so all three sit slightly below the continental middle. The cheapest pharmacy degree in the EU is Lithuanian University of Health Sciences at EUR 5,600.

This is where the three genuinely diverge, and it is the thing to plan around.

Charles closes first, on 30 April. If Charles is on your list, it sets your whole timetable — documents, credential recognition and English evidence all have to be ready two months before Masaryk's non-EU deadline.

Masaryk splits its deadline by nationality, which is easy to misread: 31 May if you are non-EU, 31 July if you are an EU applicant. Two full months apart for the same program. Find out which side you are on before you plan anything.

Comenius does not publish a fixed closing date on the page we verified. Its 2026 applicant page is active and the date is carried in the official applicant information rather than as a standing deadline. Treat that as a reason to contact the faculty early rather than as an open-ended invitation.

The most practically valuable thing in this guide is how Masaryk runs selection.

Masaryk offers entrance exams from 5 January to 15 August 2026, and the applicant chooses an available date, online or in person. That is a seven-month window with a remote option. Almost nothing else in European pharmacy works like this — most programs publish one exam day, or two if you are lucky, and expect you to travel.

It also publishes an entrance-exam exemption: eligible applicants can skip the exam entirely under published IB, A level and other criteria. If you hold one of those qualifications, check the criteria before you book anything, because the exam may not apply to you at all.

Masaryk is also the only one of the three that publishes what it wants: a secondary-school leaving qualification, with Biology and Chemistry as the required subjects.

Charles University and Comenius publish no entry requirements that we could confirm. Charles states a faculty admission assessment in Chemistry and Biology, or a published alternative assessment route; Comenius states foreign credential recognition and a faculty admission procedure. Neither gives you a grade, a score or a threshold. You cannot research either program from the page — you will have to email and ask specifically what the assessment involves and what grades it expects.

That pattern is common enough across Europe to be worth naming: we track it in the programs that do not publish their requirements.

These are modeled planning estimates over a ten-month academic year, not quoted prices.

Note what that table does: living costs are larger than tuition at all three. Brno models at about EUR 400 a month for housing and EUR 540 for living; Bratislava at EUR 390 and EUR 580. When tuition is EUR 7,500, the city you pick moves your budget more than the university does.

Across five years, tuition plus modeled living comes to roughly EUR 85,750 in Brno, EUR 87,250 in Bratislava and EUR 87,750 in Hradec Kralove. The three finish within EUR 2,000 of each other over the whole degree.

Hradec Kralove is a smaller city than Brno and is modeled on the same cost preset; if that matters to your planning, ask the faculty about local housing rather than assuming the model.

Czechia and Slovakia are both EU member states, so all three qualifications carry the automatic EU and EEA recognition route between member states.

The condition is the one that applies across continental Europe. Teaching is in English; patient contact is not. Masaryk states that Czech is required progressively for local patient communication, Charles that Czech is needed for many patient-facing placements and local practice, and Comenius that Slovak is required for patient-facing practical training.

Read the word *progressively* in Masaryk's phrasing literally. It is not a warning about year five — it describes a requirement that builds through the degree, which means the language work starts early and does not stop. Ask each faculty how many hours are in the timetable and what level you must reach before placements.

Czech and Slovak are closely related, which is genuinely relevant here: the two languages are mutually intelligible to a large degree, so the effort transfers between these three programs in a way it would not between, say, Hungarian and Romanian. It does not make the requirement disappear.

For North America, the picture is the same as everywhere in Europe. A five-year integrated pharmacy degree clears the duration screen that the four-year British MPharm does not, which is the main structural argument for looking here rather than at the UK. Beyond that, the United States and Canada evaluate foreign pharmacy qualifications through their own processes regardless of where the degree was awarded — our pharmacy licensing guide covers what those involve.

So the case for these three: an EU pharmacy degree at about EUR 7,500 a year, five years so it clears the US duration screen, in a price band so tight that cost is not the deciding factor. Decide on the calendar and on the city, and if you want the most flexible selection process of the three, Masaryk's seven-month exam window is the one that bends to you rather than the other way round.